Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Mar 30;97(3):e0021123.
doi: 10.1128/jvi.00211-23. Epub 2023 Mar 14.

The Failure of AIDS Vaccine Efficacy Trials: Where to Go from Here

Affiliations
Randomized Controlled Trial

The Failure of AIDS Vaccine Efficacy Trials: Where to Go from Here

Ronald C Desrosiers. J Virol. .

Abstract

The seven AIDS vaccine efficacy trials have yielded extremely disappointing results at great expense. Greater stringency is needed for government support of AIDS vaccine efficacy trials.

Keywords: AIDS; immune persistence; neutralizing antibodies; vaccines.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

References

    1. Richman DD, Wrin T, Little SJ, Petropoulos CJ. 2003. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci USA 100:4144–4149. doi:10.1073/pnas.0630530100. - DOI - PMC - PubMed
    1. Piantadosi A, Chohan B, Chohan V, McClelland RS, Overbaugh J. 2007. Chronic HIV-1 infection frequently fails to protect against superinfection. PLoS Pathog 3:e177. doi:10.1371/journal.ppat.0030177. - DOI - PMC - PubMed
    1. Moodie Z, Metch B, Bekker LG, Churchyard G, Nchabeleng M, Mlisana K, Laher F, Roux S, Mngadi K, Innes C, Mathebula M, Allen M, Bentley C, Gilbert PB, Robertson M, Kublin J, Corey L, Gray GE. 2015. Continued follow-up of phambili phase 2b randomized HIV-1 vaccine trial participants supports increased HIV-1 acquisition among vaccinated men. PLoS One 10:e0137666. doi:10.1371/journal.pone.0137666. - DOI - PMC - PubMed
    1. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil JG, Francis DP, Stablein D, Birx DL, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb ML, Michael NL, Kunasol P, Kim JH, Investigators M-T . 2009. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361:2209–2220. doi:10.1056/NEJMoa0908492. - DOI - PubMed
    1. Desrosiers RC. 2017. Protection against HIV acquisition in the RV144 trial. J Virol 91. doi:10.1128/JVI.00905-17. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources